GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Changchun High-Tech Industry Group Co 000661.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

72.83

-1.27%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥12.08bn

FY2016FY2025

Net income

CN¥155.0m

FY2016FY2025

Free cash flow

−CN¥1.40bn

FY2016FY2025

Shareholders' equity

CN¥22.01bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥12.08bnCN¥13.47bnCN¥14.57bnCN¥12.63bnCN¥10.75bnCN¥8.58bnCN¥7.37bnCN¥5.37bnCN¥4.10bnCN¥2.90bn
Gross profitCN¥9.92bnCN¥11.39bnCN¥12.45bnCN¥11.05bnCN¥9.31bnCN¥7.43bnCN¥6.27bnCN¥4.57bnCN¥3.36bnCN¥2.30bn
Research and developmentCN¥2.47bnCN¥2.17bnCN¥1.72bnCN¥1.36bnCN¥1.09bnCN¥681.5mCN¥370.4mCN¥328.1mCN¥289.4mCN¥205.1m
Operating incomeCN¥870.3mCN¥3.30bnCN¥5.59bnCN¥4.97bnCN¥4.72bnCN¥3.94bnCN¥2.88bnCN¥1.81bnCN¥1.14bnCN¥810.7m
Net incomeCN¥155.0mCN¥2.58bnCN¥4.53bnCN¥4.14bnCN¥3.76bnCN¥3.05bnCN¥1.78bnCN¥1.01bnCN¥661.9mCN¥484.9m
Diluted earnings per share0.396.3610.8410.179.287.535.222.961.941.43

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥30.08bnCN¥31.05bnCN¥30.74bnCN¥26.03bnCN¥22.52bnCN¥16.91bnCN¥12.72bnCN¥9.43bnCN¥7.35bnCN¥6.20bn
Cash and short-term investments—CN¥6.12bnCN¥7.59bnCN¥5.58bnCN¥5.75bnCN¥3.97bnCN¥3.95bnCN¥2.47bnCN¥2.36bnCN¥2.61bn
Total liabilitiesCN¥5.21bnCN¥4.95bnCN¥5.71bnCN¥5.22bnCN¥5.28bnCN¥4.58bnCN¥3.91bnCN¥3.09bnCN¥2.15bnCN¥1.75bn
DebtCN¥1.23bnCN¥1.52bnCN¥814.0mCN¥1.22bnCN¥1.29bnCN¥1.48bnCN¥582.6mCN¥266.8mCN¥72.5mCN¥84.7m
Shareholders' equityCN¥22.01bnCN¥23.00bnCN¥22.07bnCN¥18.05bnCN¥14.57bnCN¥10.93bnCN¥8.08bnCN¥5.31bnCN¥4.43bnCN¥3.90bn
Shares outstanding402m406m418m407m405m404m340m340m341m340m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥802.1mCN¥3.10bnCN¥5.11bnCN¥2.83bnCN¥3.33bnCN¥1.11bnCN¥1.93bnCN¥884.1mCN¥381.4mCN¥308.1m
Capital spending−CN¥2.20bn−CN¥2.18bn−CN¥2.10bn−CN¥2.09bn−CN¥2.23bn−CN¥1.10bn−CN¥844.9m−CN¥685.6m−CN¥231.5m−CN¥185.3m
Free cash flow−CN¥1.40bnCN¥923.1mCN¥3.01bnCN¥735.2mCN¥1.10bnCN¥13.9mCN¥1.09bnCN¥198.5mCN¥149.9mCN¥122.8m
Dividends paid−CN¥1.08bn−CN¥1.84bn−CN¥404.7m−CN¥321.8m−CN¥323.8m−CN¥216.2m−CN¥118.8m−CN¥137.7m−CN¥157.1m−CN¥104.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥2.96bnCN¥2.59bnCN¥2.28bnCN¥3.20bnCN¥3.61bnCN¥3.00bnCN¥3.08bnCN¥3.75bn
Gross profitCN¥2.35bnCN¥2.02bnCN¥1.69bnCN¥2.73bnCN¥2.85bnCN¥2.64bnCN¥2.50bnCN¥3.27bn
Operating incomeCN¥411.1mCN¥374.7m−CN¥808.4mCN¥241.4mCN¥581.2mCN¥564.5m−CN¥82.4mCN¥1.21bn
Net incomeCN¥199.6mCN¥275.7m−CN¥1.01bnCN¥182.0mCN¥510.2mCN¥472.7m−CN¥205.8mCN¥1.07bn
Diluted earnings per share0.500.69-2.510.451.271.18-0.512.63
Cash from operations———−CN¥491.0mCN¥649.0mCN¥573.0mCN¥8.0mCN¥1.12bn
Capital spending−CN¥262.0m−CN¥435.0m−CN¥825.0m−CN¥406.0m−CN¥380.0m−CN¥590.0m−CN¥591.0m−CN¥607.0m
Free cash flow———−CN¥897.0mCN¥269.0m−CN¥17.0m−CN¥583.0mCN¥511.0m
Total assetsCN¥30.67bnCN¥30.77bnCN¥30.08bnCN¥31.46bnCN¥31.79bnCN¥31.70bnCN¥31.05bnCN¥31.07bn
Cash and short-term investments———CN¥4.45bnCN¥6.01bnCN¥5.83bnCN¥6.12bnCN¥6.47bn
DebtCN¥293.0mCN¥1.25bnCN¥1.23bnCN¥726.2mCN¥1.49bnCN¥1.43bnCN¥1.47bnCN¥1.39bn
Shareholders' equityCN¥22.41bnCN¥22.28bnCN¥22.01bnCN¥23.01bnCN¥22.84bnCN¥23.47bnCN¥23.00bnCN¥22.98bn

Financial ratios

Data as of 20 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin82.1%84.6%85.5%87.5%86.6%86.6%
Operating margin7.2%24.5%38.4%39.3%43.9%45.9%
Net margin1.3%19.2%31.1%32.8%35.0%35.5%
Return on equity0.7%11.2%20.5%22.9%25.8%27.9%
Return on assets0.5%8.3%14.7%15.9%16.7%18.0%
Free cash flow yield10.5%18.2%24.1%16.9%19.2%7.6%
Revenue growth-10.3%-7.6%15.4%17.5%25.3%16.3%
Earnings growth-94.0%-43.0%9.5%10.2%23.3%71.6%
Current ratio3.76x4.76x3.79x4.01x3.72x3.18x
Debt to equity0.06x0.06x0.03x0.07x0.09x0.13x
Equity ratio73.2%74.1%71.8%69.3%64.7%64.7%
Interest coverage20.11x86.75x146.55x110.87x139.96x114.15x
R&D as a share of sales20.5%16.1%11.8%10.8%10.2%7.9%
Buybacks as a share of market value1.1%2.9%-2.7%-0.6%-0.1%-18.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.5%7.1%17.5%
Operating income-44.0%-26.1%3.4%
Net income-66.5%-44.9%-8.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin83.4%85.0%85.4%84.8%
Operating margin16.3%27.9%32.4%32.5%
Net margin10.7%21.6%25.3%23.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings239.915.613.416.429.259.642.929.647.139.2
Price to sales3.13.04.25.410.221.210.35.57.66.6

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 25 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.162.604.501.000.800.800.500.40
  • 2-for-1 split · 9 Jun 2020
  • 1-to-1 reverse split · 19 Jan 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.